| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| ― | £646.46K | -0.20 | ― | ― | ― | ― | |
71 Outperform | £667.15M | 9.19 | 15.73% | 4.89% | 21.29% | 32.15% | |
58 Neutral | £48.65M | 6.27 | 4.73% | ― | 0.64% | -126.10% | |
50 Neutral | £4.54M | -0.90 | -30.89% | ― | -6.07% | 50.59% | |
41 Neutral | £444.99K | -0.40 | ― | ― | ― | ― |